| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |